Epidemiological and temporal analysis of leprosy in a Brazilian endemic state

Authors

  • Karen Krystine Gonçalves Brito Federal University of Paraiba
  • Smalyanna Sgren da Costa Andrade Federal University of Paraiba
  • Emanuele Malzac Freire de Santana Federal University of Paraiba
  • Suellen Duarte de Oliveira Matos Federal University of Paraiba
  • Iraktânia Vitorino Diniz Federal University of Paraiba
  • Elizabeth Souza Silva de Aguiar Federal University of Paraiba
  • Kamila Nethielly Souza Leite Federal University of Paraiba
  • Valéria Peixoto Bezerra Federal University of Paraiba
  • Mirian Alves da Silva Federal University of Paraiba
  • Ana Paula Marques Andrade de Souza Federal University of Paraiba
  • Simone Helena dos Santos Oliveira Federal University of Paraiba
  • Maria Júlia Guimarães Oliveira Soares Federal University of Paraiba

Keywords:

Leprosy. Epidemiology. Health Profile. Nursing.

Abstract

BACKGROUND: Leprosy is endemic in Brazil, while the number of diagnosed cases of the disease has made considerable decrease since the implementation of treatment with multidrug therapy. The objective of this research, analyze time trends in sociodemographic and clinical-epidemiological profile of leprosy in Paraíba, in the 2001-2011 period, and identify differences between the epidemiological trends within the period. METHODS: Epidemiological study of time, retrospective and documentary based series, produced using secondary data and Notification Diseases Information System. RESULTS: They evaluated data on 10.476 Sheets Notification single, between the years 2001-2011, based on descriptive and inferential statistics. The results showed statistically significant differences between the two areas evaluated time, starting with the suggestive reduction of 42.7% of cases in P2 (2007-2011), although this timeline, the clinical characterization refers to the most serious states or late leprosy. CONCLUSION: Leprosy remains a relevant epidemiological dilemma, especially in view of the increase in the proportion of MB cases, glimpsed for the period studied.

References

World Health Organization. Global Health Observatory Data Repository: Number of reported cases Data by country [Internet]. 2015 [cited 2015 Set. 06]. Available from: http://www.who.int/lep/classification/en/

Penna MLF, Oliveira ML, Penna GO. The epidemiological behaviour of leprosy in Brazil. Lepr Rev. 2009; 80: 332–44.

Penna ML, Temporao JG, Grossi MA, Penna GO. Leprosy control: knowledge shall not be neglected. J Epidemiol Community Health. 2011; 65: 473–4.

Organização Mundial da Saúde. Estratégia global aprimorada para redução adicional da carga da hanseníase (Período do plano: 2011-2015) [Internet]. 2010 [cited 2015 Set. 08]. Available from: http://bvsms.saude.gov.br/bvs/publicacoes/estrategia_global_aprimorada_reducao_hanseniase.pdf

Penna MLF, Penna GO. Leprosy frequency in the world, 1999-2010. Mem Inst Oswaldo Cruz. 2012; 107(Suppl. I): 3-12.

World Health Organization. The final push towards elimination of leprosy: strategic plan 2000-2005 [Internet]. 2000 [cited 2015 Set. 08]. Available from: http://www.who.int/lep/resources/Final_Push_%20QA.pdf.

Organização Mundial de Saúde. Estratégia Global para Aliviar a Carga da Hanseníase e Manter as Atividades de Controle da Hanseníase (Período do Plano: 2006-2010) [Internet]. 2005 [cited 2015 Set. 07]. Available from: http://www.saude.sp.gov.br/resources/ses/perfil/gestor/documentos-tecnicos/informes-tecnicos/estrategia_global_para_controle_de_hanseniase.pdf

Brasil. Resolução nº 466, de 12 de dezembro de 2012. Dispõe sobre diretrizes e normas regulamentadoras de pesquisas envolvendo seres humanos. Diário Oficial da República Federativa do Brasil. Brasília: Ministério da Saúde; 2012.

Crespo MJ, Gonçalves A. Avaliação das possibilidades de controle da hanseníase a partir da poliquimioterapia. Rev Portuguesa de Saúde Pública. 2014; 32(1): 80–8.

WCS Smith. A Research Strategy to Develop New Tools to Prevent Leprosy, Improve Patient Care and Reduce the Consequences of Leprosy. Lepr Rev. 2012; 83(1): 6 – 15.

Gonçalves A. Realities of leprosy control: updating scenarios. Rev bras epidemiol. 2013; 16(3): 611-21.

Bobosha K, Tang ST, van der Ploeg-van Schip JJ, Bekele Y, Martins MV, Lund O, et al. Mycobacterium leprae virulence-associated peptides are indicators of exposure to M. leprae in Brazil, Ethiopia and Nepal. Mem Inst Oswaldo Cruz. 2012; 107(Suppl. I): 112-23.

Sarno EN, Duppre NC, Sales AM, Hacker MA, Nery JÃ, Matos HJ. Leprosy exposure, infection and disease: a 25-year surveillance study of leprosy patient contacts. Mem Inst Oswaldo Cruz. 2012; 107(8): 1054-9.

Ministério da Saúde. Secretaria de Vigilância em Saúde. Situação epidemiológica da hanseníase no Brasil: análise de indicadores selecionados na última década e desafios para eliminação. Bol Epidemiol [Internet]. 2013 [cited 2015 Set. 08]; 44(11): [about 12 p.]. Available from: http://portalsaude.saude.gov.br/images/pdf/2014/junho/11/BE-2013-44--11----Hanseniase.pdf

World Health Organization. Global leprosy situation 2010. Weekly Epidemiol Rec [Internet]. 2010 [cited 2015 Set. 08]; 85: [about 11p.]. Available from: http://www.who.int/wer/2010/wer8535.pdf?ua=1

World Health Organization. Global leprosy: update on the 2012 situation. Weekly Epidemiological Rec [Internet]. 2013 [cited 2015 Set 06]; 88(35): [about 15p.]. Available from: http://www.who.int/wer/2013/wer8835.pdf

Talhari S, Grossi MAF, Oliveira ML, Gontijo B, Talhari C, Penna GO. Hansen’s disease: a vanishing disease?. Mem Inst Oswaldo Cruz. 2012; 107(Suppl. I): 13-6.

Lima HMN, Sauaia N, Costa VRL, Coelho Neto GT, Figueiredo PMS. Perfil epidemiológico dos pacientes com hanseníase atendidos em Centro de Saúde em São Luís, MA. Rev Bras Clin Med. 2010; 8(4):323-7.

Monteiro LD, Martins-Melo FR, Brito AL, Lima MS, Alencar CH, Heukelbach J. Tendências da hanseníase no Tocantins, um estado hiperendêmico do Norte do Brasil, 2001-2012. Cad Saúde Pública. 2015 May; 31(5): 971-80.

Corrêa RGCF, Aquino DMC, Caldas AJM, Amaral DKCR, França FS, Mesquita ERRBPL. Epidemiological, clinical, and operational aspects of leprosy patients assisted at a referral service in the state of Maranhão, Brazil. Rev Soc Bras Med. Trop. 2012 Feb; 45(1): 89-94.

Araújo AERA, Aquino DMC, Goulart IMB, Pereira SRF, Figueiredo IA, Serra HO, et al. Neural complications and physical disabilities in leprosy in a capital of northeastern Brazil with high endemicity. Rev bras epidemiol. 2014 Out - dez; 17(4): 899-910.

World Health Organization. Leprosy elimination: Classification of leprosy. [cited 2015 Set 06]. Available from: http://www.who.int/lep/classification/en/

Xavier MB, Tavares NCS, Corrêa SC, Gonçalves BK, Ramos MMAB, Macedo GMM. Correlação entre as formas clínicas da hanseníase e o grau de incapacidade neurológica. Revista Paraense de Medicina. 2014; 28 (2).

Galvão PRS, Ferreira AT, Maciel MGG, Almeida RP, Hinders D, Schreuder PA, et al. Uma Avaliação do sistema de informação SINAN usado no Programa de Controle de Hanseníase no estado do Pernambuco, Brasil. Cad Saúde Coletiva. 2009; 17(1): 87-102.

Bovendorp ACC, Oliveira MB, Saleme PS, Lyon S, Bastos M. Qualidade de registros de hanseníase em centro de referência no estado de Minas Gerais, no período de 2006 a 2010. Rev Med Minas Gerais. 2014; 24(Supl 6): S61-5.

Downloads

Published

2016-06-09

Issue

Vol. 9 (2016)

Section

Epidemiology

License

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access and Benefits of Publishing Open Access).

 

 

Most read articles by the same author(s)

<< < 1 2